$5.190
0.000 (0.00%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BMGL Prediction & Forecast by Similar Chart Analysis
Alphio's BMGL stock price prediction model matches the current Basel Medical Group Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.24 (+0.99%). The 1-week path is $5.21 (+0.40%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Basel Medical Group Ltd Stock?
Basel Medical Group Ltd (BMGL) appears to be a good buy right now, as it has shown a strong recent performance with a 5-day change of +12.31% and a 20-day change of +61.20%. The stock is currently priced at $5.11, which is significantly below its 52-week high of $18.72, indicating potential for recovery. Additionally, the RSI is at 92.981, suggesting that the stock is in a strong upward momentum. However, investors should be cautious of the high debt-to-equity ratio of 137.69%, which poses a risk to financial stability.
BMGL stock price ended at $5.19 on Thursday, after rising 0.00%
Basel Medical Group Ltd (BMGL) last closed at $5.1900001, gaining +0.00%. These facts feed the 1-day and 1-week BMGL price prediction above.
Forecast Drivers
Basel Medical Group Ltd (BMGL) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BMGL, ranked by similarity.
Seasonality analysis for BMGL
Historically the probability of a positive November return for BMGL is 0.00%. January offers the highest probability of a positive month at 95.00%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BMGL
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.76 | $2.24 | $2.31 | -56.80% |
| Dec 2026 | $2.01 | $2.17 | $2.44 | -58.16% |
In 2026, Basel Medical Group Ltd (BMGL) is projected to range from $1.76 to $2.44.
Basel Medical Group Ltd 2026 monthly forecast
In Nov 2026, Basel Medical Group Ltd is projected to average $2.24, with a low of $1.76 and high of $2.31.
In Dec 2026, Basel Medical Group Ltd is projected to average $2.17, with a low of $2.01 and high of $2.44.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.